- Home
- PROF vs FBRX Comparison
PROF vs FBRX Comparison
Compare PROF & FBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PROF
- FBRX
- Stock Information
- Founded
- PROF N/A
- FBRX N/A
- Country
- PROF Canada
- FBRX United States
- Employees
- PROF N/A
- FBRX N/A
- Industry
- PROF Medical/Dental Instruments
- FBRX Biotechnology: Pharmaceutical Preparations
- Sector
- PROF Health Care
- FBRX Health Care
- Exchange
- PROF Nasdaq
- FBRX Nasdaq
- Market Cap
- PROF 134.3M
- FBRX 154.5M
- IPO Year
- PROF N/A
- FBRX N/A
- Fundamental
- Price
- PROF $4.11
- FBRX $10.92
- Analyst Decision
- PROF Strong Buy
- FBRX Strong Buy
- Analyst Count
- PROF 1
- FBRX 3
- Target Price
- PROF $11.00
- FBRX $68.00
- AVG Volume (30 Days)
- PROF 167.1K
- FBRX 63.8K
- Earning Date
- PROF 11-06-2025
- FBRX 08-14-2025
- Dividend Yield
- PROF N/A
- FBRX N/A
- EPS Growth
- PROF N/A
- FBRX N/A
- EPS
- PROF N/A
- FBRX N/A
- Revenue
- PROF $11,840,000.00
- FBRX N/A
- Revenue This Year
- PROF $60.07
- FBRX N/A
- Revenue Next Year
- PROF $121.80
- FBRX N/A
- P/E Ratio
- PROF N/A
- FBRX N/A
- Revenue Growth
- PROF 59.81
- FBRX N/A
- 52 Week Low
- PROF $3.90
- FBRX $4.11
- 52 Week High
- PROF $9.17
- FBRX $28.68
- Technical
- Relative Strength Index (RSI)
- PROF 30.34
- FBRX 48.35
- Support Level
- PROF $4.38
- FBRX $10.65
- Resistance Level
- PROF $4.69
- FBRX $11.57
- Average True Range (ATR)
- PROF 0.21
- FBRX 0.93
- MACD
- PROF -0.03
- FBRX -0.04
- Stochastic Oscillator
- PROF 11.04
- FBRX 19.22
About PROF Profound Medical Corp.
Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.
About FBRX Forte Biosciences Inc.
Forte Biosciences Inc is a biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary therapeutic molecule with potentially broad autoimmune applications in such indications as graft-versus-host disease (GvHD), vitiligo, alopecia areata, and type 1 diabetes (T1D).